Biochemical molecular analysis revealed that TIPE2 could reduce the activation of RAC1 and MMP9 by binding to RAC1, thereby suppressing gastric cancer cell metastasis (Xuelei et al., 2013). Here, TIPE2 is linked to gastric cancer.